Coronary atherosclerosis can regress with very intensive statin therapy

Article Type
Changed
Wed, 08/22/2018 - 11:14
Display Headline
Coronary atherosclerosis can regress with very intensive statin therapy
Interpreting the ASTEROID trial
Article PDF
Author and Disclosure Information

Ilke Sipahi, MD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Stephen J. Nicholls, MBBS, PhD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

E. Murat Tuzcu, MD
Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Steven E. Nissen, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; president, American College of Cardiology; principal investigator, ASTEROID trial

Address: Ilke Sipahi, MD, Department of Cardiovascular Medicine, JJ65, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Sipahi has received an educational grant from Pfizer.

Dr. Nicholls has received lecture honoraria from AstraZeneca and Pfizer.

Dr. Tuzcu received grant support from Pfizer and Takeda and lecture honoraria from Pfizer.

Dr. Nissen has received research support from AstraZeneca, Eli Lilly, Pfizer, Takeda, Sankyo, and Sanofi-Aventis. He has also consulted for a number of pharmaceutical companies without financial compensation. All his honoraria, consulting fees, or other payments from any for-profit entity are paid directly to charity, so that neither income nor tax deduction is received.

Issue
Cleveland Clinic Journal of Medicine - 73(10)
Publications
Topics
Page Number
937-944
Sections
Author and Disclosure Information

Ilke Sipahi, MD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Stephen J. Nicholls, MBBS, PhD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

E. Murat Tuzcu, MD
Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Steven E. Nissen, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; president, American College of Cardiology; principal investigator, ASTEROID trial

Address: Ilke Sipahi, MD, Department of Cardiovascular Medicine, JJ65, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Sipahi has received an educational grant from Pfizer.

Dr. Nicholls has received lecture honoraria from AstraZeneca and Pfizer.

Dr. Tuzcu received grant support from Pfizer and Takeda and lecture honoraria from Pfizer.

Dr. Nissen has received research support from AstraZeneca, Eli Lilly, Pfizer, Takeda, Sankyo, and Sanofi-Aventis. He has also consulted for a number of pharmaceutical companies without financial compensation. All his honoraria, consulting fees, or other payments from any for-profit entity are paid directly to charity, so that neither income nor tax deduction is received.

Author and Disclosure Information

Ilke Sipahi, MD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Stephen J. Nicholls, MBBS, PhD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

E. Murat Tuzcu, MD
Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Steven E. Nissen, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; president, American College of Cardiology; principal investigator, ASTEROID trial

Address: Ilke Sipahi, MD, Department of Cardiovascular Medicine, JJ65, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Sipahi has received an educational grant from Pfizer.

Dr. Nicholls has received lecture honoraria from AstraZeneca and Pfizer.

Dr. Tuzcu received grant support from Pfizer and Takeda and lecture honoraria from Pfizer.

Dr. Nissen has received research support from AstraZeneca, Eli Lilly, Pfizer, Takeda, Sankyo, and Sanofi-Aventis. He has also consulted for a number of pharmaceutical companies without financial compensation. All his honoraria, consulting fees, or other payments from any for-profit entity are paid directly to charity, so that neither income nor tax deduction is received.

Article PDF
Article PDF
Interpreting the ASTEROID trial
Interpreting the ASTEROID trial
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Page Number
937-944
Page Number
937-944
Publications
Publications
Topics
Article Type
Display Headline
Coronary atherosclerosis can regress with very intensive statin therapy
Display Headline
Coronary atherosclerosis can regress with very intensive statin therapy
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media